CypD ablation is sufficient to prevent HCC in this model however and given the unique subcellular localization of CypD and its role, unlike other cyclophilins, in the mPTP, it is likely that if depletion of another cyclophilin also reduced HCC burden it would be through a different mechanism. The gene discussed is PPIB; the disease is hepatocellular carcinoma.